<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04736875</url>
  </required_header>
  <id_info>
    <org_study_id>3</org_study_id>
    <nct_id>NCT04736875</nct_id>
  </id_info>
  <brief_title>Arteriovenous Fistula Maturation Evaluation Study. FAME Study</brief_title>
  <official_title>Study of the Hemodynamic and Clinical Maturation of the Native Arteriovenous Fistula for Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medifil AE</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medifil AE</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of the features of hemodynamic and clinical maturation of the native arteriovenous&#xD;
      fistula for hemodialysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-center, observational study, investigating the clinical and&#xD;
      hemodynamic features of maturation of hemodialysis native arteriovenous fistula (AVF).&#xD;
      Hemodynamic features under investigation are the diameter of the feeding brachial artery,&#xD;
      volume of flow (VF) measured with transcutaneous Duplex ultrasound (DUS), resistivity index&#xD;
      (RI), diameter and wall thickness of the efferent vein, measured at days 1, 2, 3, 4, 5, 6, 7,&#xD;
      14, 21, 30, 60 and 90 post creation. Clinical features of maturation are the time of first&#xD;
      access successful cannulation and the performance of three consecutive adequate dialysis&#xD;
      sessions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">February 22, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 22, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 1 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 2 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 3 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 4 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 5 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 6 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 7 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 14 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 21 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 28 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 60 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume flow</measure>
    <time_frame>day 90 post access creation</time_frame>
    <description>Volume of flow in brachial artery in L/min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 1 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 2 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 3 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 4 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 5 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 6 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 7 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 14 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 21 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 28 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 60 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>brachial artery diameter</measure>
    <time_frame>day 90 post access creation</time_frame>
    <description>Diameter of the Brachial artery in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 1 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 2 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 3 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 4 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 5 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 6 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 7 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 14 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 21 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 28 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 60 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive index RI</measure>
    <time_frame>day 90 post access creation</time_frame>
    <description>Calculation of the Resistive Index of the Brachial artery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 1 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 2 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 3 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 4 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 5 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 6 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 7 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 14 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 21 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 28 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 60 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diameter of the efferent vein</measure>
    <time_frame>day 90 post access creation</time_frame>
    <description>Diameter of the the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 1 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 2 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 3 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 4 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 5 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 6 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 7 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 14 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 21 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 28 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 60 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall thickness of the efferent vein</measure>
    <time_frame>day 90 post access creation</time_frame>
    <description>Wall thickness of the efferent vein in mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of first successful cannulation</measure>
    <time_frame>30 and 60 days</time_frame>
    <description>Time period between access creation and first successful cannulation for hemodialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful hemodialysis</measure>
    <time_frame>30 and 60 days</time_frame>
    <description>Three consecutive adequate hemodialysis sessions based on measurement of single pool kt/V</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary patency</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of total patent arteriovenous fistulae without the need of additional interventions assessed by transcutaneous dopler ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon-Nephrologist access site selection concordance</measure>
    <time_frame>At access creation (day 0)</time_frame>
    <description>Record of the opinion regarding the site of vascular access creation between the nephrologist performing preoperative mapping and the surgeon performing access creation with the use of a questionaire</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>End-stage Renal Disease</condition>
  <condition>Hemodialysis Access Failure</condition>
  <condition>Vascular Access Maturation</condition>
  <condition>Native Arteriovenous Fistula</condition>
  <arm_group>
    <arm_group_label>Dialysis</arm_group_label>
    <description>Patients with hemodialysis-dependent end-stage renal disease and a newly created native arteriovenous fistula</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Doppler ultrasound study</intervention_name>
    <description>Transcutaneous Doppler ultrasound (DUS) study was performed at the mid brachial artery to assess diameter, VF and RI, and at the mid segment of the efferent vein to assess the diameter and wall thickness.</description>
    <arm_group_label>Dialysis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will recruit patients with end-stage renal disease eligible for native&#xD;
        arteriovenous fistula creation for hemodialysis fulfilling the study's inclusion critera.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Hemodialysis patients&#xD;
&#xD;
          2. new native arteriovenous fistula (AVF)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients not eligible for AVF creation&#xD;
&#xD;
          2. Patients with non compensated heart failure New York Heart Association stages 3 and 4&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ioannis E Giannikouris, MD, PhD</last_name>
    <phone>+302169003010</phone>
    <email>igiannikouris@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nephrologiki SA Private Nephrological Center</name>
      <address>
        <city>Koropi</city>
        <state>Attiki</state>
        <zip>19400</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioannis Emmanouil Giannikouris, Md, MsC, PhD</last_name>
      <phone>+306946501700</phone>
      <email>igiannikouris@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Stavros Spiliopoulos, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 27, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nefrolgiki SA Hemodialysis Center</investigator_affiliation>
    <investigator_full_name>Ioannis Emmanouel Giannikouris</investigator_full_name>
    <investigator_title>Consultant Nephrologist</investigator_title>
  </responsible_party>
  <keyword>hemodialysis</keyword>
  <keyword>native arteriovenous fistula</keyword>
  <keyword>maturation</keyword>
  <keyword>feeding artery</keyword>
  <keyword>efferent vein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

